Brought to you by 
Nestle boosts personalized nutritionals initiative with Prometheus buy
Jun 2011
Executive Summary
In a deal that one Bank Vontobel analyst estimated at $567mm-1bn, Nestle Health Science SA, a newly formed division of Nestle SA, has acquired privately held Prometheus Laboratories Inc. (drug and diagnostic in-licenser).
Deal Industry
-
Biotechnology
- Pharmacogenetics-Pharmacogenomics
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
-
Pharmaceuticals
- Specialty Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Acquisition of Private Biotech
- Full Acquisition
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
Advertisement
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Nestle boosts personalized nutritionals initiative with Prometheus buy
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice